Joyce E. Ohm

8.3k total citations · 3 hit papers
63 papers, 6.3k citations indexed

About

Joyce E. Ohm is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Joyce E. Ohm has authored 63 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Joyce E. Ohm's work include Epigenetics and DNA Methylation (21 papers), Birth, Development, and Health (9 papers) and Cancer-related gene regulation (8 papers). Joyce E. Ohm is often cited by papers focused on Epigenetics and DNA Methylation (21 papers), Birth, Development, and Health (9 papers) and Cancer-related gene regulation (8 papers). Joyce E. Ohm collaborates with scholars based in United States, Canada and Belgium. Joyce E. Ohm's co-authors include Stephen B. Baylin, David P. Carbone, Kelly M. McGarvey, Dmitry I. Gabrilovich, James G. Herman, Sorena Nadaf, D. Neil Watkins, Kevin Pruitt, Leslie Cope and Tatsuhiro Ishida and has published in prestigious journals such as Nature Genetics, Nature reviews. Cancer and Environmental Science & Technology.

In The Last Decade

Joyce E. Ohm

58 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

2006 1.3k citations Stephen B. Baylin, Joyce E. Ohm profile →
A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

2007 805 citations Joyce E. Ohm, Kelly M. McGarvey et al. Nature Genetics profile →
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options

2022 143 citations Jae Young So, Joyce E. Ohm et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joyce E. Ohm United States	29	4.3k	1.8k	999	998	738	63	6.3k
Paresh Vyas United Kingdom	52	4.4k 1.0×	1.3k 0.8×	899 0.9×	1.8k 1.8×	406 0.6×	235	9.4k
Mark A. Dawson Australia	33	5.7k 1.3×	1.3k 0.8×	1.2k 1.2×	700 0.7×	490 0.7×	86	7.5k
Charles N. Landen United States	49	4.5k 1.0×	2.4k 1.4×	1.6k 1.6×	878 0.9×	468 0.6×	114	7.5k
Jaroslav Jelı́nek United States	49	5.8k 1.3×	1.1k 0.6×	1.3k 1.3×	448 0.4×	715 1.0×	159	8.3k
Giuseppe Viglietto Italy	48	5.4k 1.2×	2.3k 1.3×	1.6k 1.6×	687 0.7×	803 1.1×	150	8.2k
Hallgeir Rui United States	50	3.1k 0.7×	3.5k 2.0×	1.3k 1.3×	1.4k 1.4×	562 0.8×	204	6.8k
Johannes H. Schulte Germany	42	4.3k 1.0×	1.3k 0.7×	2.1k 2.1×	520 0.5×	368 0.5×	176	6.3k
Leandro Cerchietti United States	42	2.9k 0.7×	1.6k 0.9×	725 0.7×	992 1.0×	539 0.7×	132	5.4k
Charles V. Clevenger United States	44	2.6k 0.6×	1.9k 1.1×	690 0.7×	795 0.8×	323 0.4×	102	5.2k
Pepper Schedin United States	46	2.0k 0.5×	3.5k 2.0×	1.5k 1.5×	882 0.9×	489 0.7×	119	6.2k

Countries citing papers authored by Joyce E. Ohm

Since Specialization

Citations

This map shows the geographic impact of Joyce E. Ohm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce E. Ohm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce E. Ohm more than expected).

Fields of papers citing papers by Joyce E. Ohm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce E. Ohm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce E. Ohm. The network helps show where Joyce E. Ohm may publish in the future.

Co-authorship network of co-authors of Joyce E. Ohm

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce E. Ohm. A scholar is included among the top collaborators of Joyce E. Ohm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce E. Ohm. Joyce E. Ohm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heske, Christine M., Filemon S. Dela Cruz, Sarah Burkhead Whittle, et al.. (2025). New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee. Pediatric Blood & Cancer. 72(10). e31917–e31917.

Anderson, Cindy M., Yihong Zhao, Jodi L. Ford, et al.. (2023). Epigenetic Implications of Neighborhood Disorder and Psychological Distress among Pregnant Black Women. Western Journal of Nursing Research. 45(9). 780–788. 1 indexed citations

Krishnan, Nithya, Swathi Ramakrishnan, Eduardo Cortes Gomez, et al.. (2022). STAG2 Expression is Associated with Adverse Survival Outcomes and Regulates Cell Phenotype in Muscle-invasive Bladder Cancer. Cancer Research Communications. 2(10). 1129–1143. 7 indexed citations

Gupta, Ajay, et al.. (2022). WEE1 Inhibition Augments CDC7 (DDK) Inhibitor–induced Cell Death in Ewing Sarcoma by Forcing Premature Mitotic Entry and Mitotic Catastrophe. Cancer Research Communications. 2(6). 471–482. 8 indexed citations

Anderson, Cindy M., Jodi L. Ford, Amy R. Mackos, et al.. (2022). DNA Methylation Patterns of Glucocorticoid Pathway Genes in Preterm Birth Among Black Women. Biological Research For Nursing. 24(4). 493–502. 4 indexed citations

So, Jae Young, Joyce E. Ohm, Stan Lipkowitz, & Yang Li. (2022). Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacology & Therapeutics. 237. 108253–108253. 143 indexed citations breakdown →

Giurgescu, Carmen, Jodi L. Ford, Amy R. Mackos, et al.. (2021). Methodologic Considerations for Epigenomic Investigation of Preterm Birth in African American Women. Western Journal of Nursing Research. 44(1). 81–93. 2 indexed citations

Halcrow, Peter W., Miranda L. Lynch, Jonathan D. Geiger, & Joyce E. Ohm. (2021). Role of endolysosome function in iron metabolism and brain carcinogenesis. Seminars in Cancer Biology. 76. 74–85. 29 indexed citations

Gomez, Eduardo Cortes, Ajay Gupta, Clare J. Twist, et al.. (2021). Clinicopathologic and molecular analysis of aBCOR–CCNB3undifferentiated sarcoma of the kidney reveals significant epigenetic alterations. Molecular Case Studies. 8(1). a005942–a005942. 3 indexed citations

10.

Ramakrishnan, Swathi, Monika Rak, Qiang Hu, et al.. (2019). Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death and Differentiation. 26(10). 2100–2114. 74 indexed citations

11.

Sun, Yuyang, Senthil Selvaraj, James D. Foster, et al.. (2018). MPP+ decreases store-operated calcium entry and TRPC1 expression in Mesenchymal Stem Cell derived dopaminergic neurons. Scientific Reports. 8(1). 11715–11715. 17 indexed citations

12.

Ohm, Joyce E.. (2018). Environmental Exposures, the Epigenome, and African American Women’s Health. Journal of Urban Health. 96(S1). 50–56. 12 indexed citations

13.

Raza, Shaneabbas, Joyce E. Ohm, Archana Dhasarathy, et al.. (2015). The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. Molecular and Cellular Biochemistry. 410(1-2). 187–195. 53 indexed citations

14.

Mohammad, Helai P., Yi Cai, Kelly M. McGarvey, et al.. (2009). Polycomb CBX7 Promotes Initiation of Heritable Repression of Genes Frequently Silenced with Cancer-Specific DNA Hypermethylation. Cancer Research. 69(15). 6322–6330. 61 indexed citations

15.

Yi, Joo Mi, Hsing-Chen Tsai, Sabine C. Glöckner, et al.. (2008). Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors. Cancer Research. 68(19). 8094–8103. 115 indexed citations

16.

McGarvey, Kelly M., Leander Van Neste, Leslie Cope, et al.. (2008). Defining a Chromatin Pattern that Characterizes DNA-Hypermethylated Genes in Colon Cancer Cells. Cancer Research. 68(14). 5753–5759. 94 indexed citations

17.

Tiwari, Vijay, Leslie Cope, Kelly M. McGarvey, Joyce E. Ohm, & Stephen B. Baylin. (2008). A novel 6C assay uncovers Polycomb-mediated higher order chromatin conformations. Genome Research. 18(7). 1171–1179. 97 indexed citations

18.

Ohm, Joyce E., Kelly M. McGarvey, Xiaobing Yu, et al.. (2007). A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genetics. 39(2). 237–242. 805 indexed citations breakdown →

19.

Dikov, Mikhail M., Joyce E. Ohm, Neelanjan Ray, et al.. (2005). Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation. The Journal of Immunology. 174(1). 215–222. 199 indexed citations

20.

Ohm, Joyce E., Joseph M. Amann, & David P. Carbone. (2004). Acquired EGFr TKI resistance associated with mutation of the EGFr.. Cancer Research. 64. 570–570. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact